Artelo Biosciences Inc.
13F holders, Q1 2025 (March 31)8holders +2
2new positions
0sold out
1famous investor
$0.88avg. 13F price*
At the end of Q1 2025, 8 institutions reported holding Artelo Biosciences Inc. in their 13F filings, up 2 from Q4 2024. 2 opened new positions and 0 sold out. The largest holders were Geode Capital Management, LLC ($23K), Citadel Advisors ($20K) and Susquehanna International Group, LLP ($18K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Artelo Biosciences Inc.
- CUSIP
- 04301G508
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $38K |
| Exits | 0 | $0 |
All 13F filers, Q4 2024 → Q1 2025: 52,592 shares bought and 525 shares sold, net +52,067 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 8 holders
| Geode Capital Management, LLC | 0.00% | Add +54.3% | 26,762 | $23K |
| Citadel Advisors | 0.00% | New | 22,706 | $20K |
| Susquehanna International Group, LLP | 0.00% | New | 20,388 | $18K |
| UBS Group AG | 0.00% | Reduce -4.0% | 12,772 | $11K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +2.2% | 3,903 | $3K |
| Bank of America Corp. | 0.00% | Add +3.9% | 27 | $24 |
| Morgan Stanley | 0.00% | No change | 20 | $18 |
| Rothschild Investment LLC | 0.00% | No change | 8 | $7 |
"% of holder's portfolio" is ARTELO BIOSCIENCES INC's weight in each manager's 13F, not the share of Artelo Biosciences Inc. the manager owns.